ADP
66
2
PWR
72
2
DVN
18
2
JWN
42
2
K
57
4
LH
45
3
LMT
32
-12
AMAT
42
6
SYY
49
2
URBN
42
4
AN
54
4
HPE
61
6
FTI
76
3
VRSN
57
4
AAL
53
-4
SLG
66
2
ISRG
76
2
XEL
69
2
MLM
51
3
VTR
54
5
ADP
66
2
PWR
72
2
DVN
18
2
JWN
42
2
K
57
4
LH
45
3
LMT
32
-12
AMAT
42
6
SYY
49
2
URBN
42
4
AN
54
4
HPE
61
6
FTI
76
3
VRSN
57
4
AAL
53
-4
SLG
66
2
ISRG
76
2
XEL
69
2
MLM
51
3
VTR
54
5
Financhill
Back

Astellas Pharma Vs. Nxera Pharma Industry Stock Comparison

Sell
23

ALPMY
Astellas Pharma

Last Price:
10.05
Seasonality Move:
1.46%
Sell
49

SOLTF
Nxera Pharma

Last Price:
8.05
Seasonality Move:
14.44%
Sell
23
Astellas Pharma (ALPMY) is a Sell

Is Astellas Pharma a Buy, Sell or Hold?

  • The current Astellas Pharma [ALPMY] share price is $10.13. The Score for ALPMY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALPMY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Nxera Pharma (SOLTF) is a Sell

Is Nxera Pharma a Buy, Sell or Hold?

  • The current Nxera Pharma [SOLTF] share price is $8.05. The Score for SOLTF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SOLTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALPMY Stock Price Chart

What is Astellas Pharma's stock price today?

  • The Astellas Pharma share price today is $10.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALPMY is experiencing slight selling pressure.

SOLTF Stock Price Chart

What is Nxera Pharma's stock price today?

  • The Nxera Pharma share price today is $8.05
    The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.

ALPMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 28.15 Sell
Chaikin Money Flow: -118144 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.62 - 11.76) Sell
Bollinger Bands (100): (10.69 - 12.17) Sell

SOLTF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 52.73 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.32 - 8.02) Buy
Bollinger Bands (100): (8.01 - 10.11) Sell

ALPMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.47 Sell
20-day SMA: 11.08 Sell
50-day SMA: 11.51 Sell
200-day SMA: 10.83 Sell
8-day EMA: 10.45 Sell
20-day EMA: 10.9 Sell
50-day EMA: 11.28 Sell
200-day EMA: 11.38 Sell

SOLTF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.05 Sell
20-day SMA: 7.73 Buy
50-day SMA: 8.28 Sell
200-day SMA: 9.4 Sell
8-day EMA: 8.01 Buy
20-day EMA: 7.94 Buy
50-day EMA: 8.26 Sell
200-day EMA: 9.39 Sell

Astellas Pharma Earnings Growth & ALPMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nxera Pharma Earnings Growth & SOLTF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Astellas Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nxera Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):